Robert P. Nelson
Division of Hematology/Oncology
Department of Medicine
Indiana University School of Medicine
Indianapolis
USA
Name/email consistency: high
- Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia. Nelson, R.P., Yu, M., Schwartz, J.E., Robertson, M.J., Hromas, R., Fausel, C.A., Vance, G.H., Dlouhy, S.R., Baute, J.A., Cox, E.A., Wood, L.L., Srivastava, S., Robertson, K.A., Haut, P.R., Farag, S.S., Abonour, R., Cornetta, K., Cripe, L.D. Bone Marrow Transplant. (2010)
- Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review. Nelson, R.P., Pascuzzi, R.M., Kessler, K., Walsh, L.E., Faught, P.P., Ramanuja, S., Pescovitz, M.D., Loehrer, P.J. J. Clin. Neuromuscul. Dis (2009)
- Paraneoplastic syndromes in thymoma: an immunological perspective. Nelson, R.P., Pascuzzi, R.M. Curr. Treat. Options. Oncol (2008)
- Bacterial meningitis and inflammation. Nelson, R.P. Curr. Opin. Neurol. (2006)
- Desensitization to imatinib in patients with leukemia. Nelson, R.P., Cornetta, K., Ward, K.E., Ramanuja, S., Fausel, C., Cripe, L.D. Ann. Allergy Asthma Immunol. (2006)